C4.4A as a candidate marker in the diagnosis of colorectal cancer

British Journal of Cancer

Volumn 97, Issue 8, 2007, Pages 1146-1156

  Paret, C ^a   Hildebrand, D ^a   Weitz, J ^b   Kopp Schneider, A ^a   Kuhn, A ^a   Beer, A ^a   Hautmann, R ^c   Zoller M ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Antigen shedding; C4.4A; Colorectal cancer; Galectin 3; Glycosylation

Indexed keywords

C4.4A ANTIGEN; CO 029 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; EPITOPE; GALECTIN 3; OLIGOMER; RABBIT ANTISERUM; TETRASPANIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; COLITIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 35348916582     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604012     Document Type: Article

References (55)

1. Aguirre Ghiso JA, Kovalski K, Ossowski L (1999) Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89-104
2. Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius HJ (1999) Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J Cancer Res Clin Oncol 125: 461-474
3. Armstrong A, Eck SL (2003) EpCAM: a new therapeutic target for an old cancer antigen. Cancer Biol Ther 2: 320-326
4. Barondes SH, Cooper DN, Gitt MA, Leffler H (1994) Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269: 20807-20810
5. Beaufort N, Leduc D, Eguchi H, Mengele K, Hellmann D, Masegi T, Kamimura T, Yasuoka S, Fend F, Chignard M, Pidard D (2007) The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions. Am J Physiol Lung Cell Mol Physiol 292: L1263-L1272
6. Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A (2005) Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma. Oncol Rep 14: 777-782
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771
8. Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23: 77-99
9. Chen Y, Zheng B, Robbins DH, Lewin DN, Mikhitarian K, Graham A, Rumpp L, Glenn T, Gillanders WE, Cole DJ, Lu X, Hoffman BJ, Mitas M (2007) Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer 120: 1511-1517
10. Chiaradonna F, Fontana L, Iavarone C, Carriero MV, Scholz G, Barone MV, Stoppelli MP (1999) Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence. EMBO J 18: 3013-3023
11. Claas C, Herrmann K, Matzku S, Möller P, Zöller M (1996) Developmentally regulated expression of metastasis-associated antigens in the rat. Cell Growth Differ 7: 663-678
12. Dainiak N (1991) Surface membrane-associated regulation of cell assembly, differentiation, and growth. Blood 78: 264-276
13. Devitt G, Meyer C, Wiedemann N, Eichmuller S, Kopp-Schneider A, Haferkamp A, Hautmann R, Zöller M (2006) Serological analysis of human renal cell carcinoma. Int J Cancer 118: 2210-2219
14. Dolo V, Adobati E, Canevari S, Picone MA, Vittorelli ML (1995) Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13: 277-286
15. Endo K, Kohnoe S, Tsujita E, Watanabe A, Nakashima H, Baba H, Maehara Y (2005) Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res 25: 3117-3121
16. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA (2003) hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 88: 579-585
17. Fries F, Nazarenko I, Hess J, Claas A, Angel P, Zöller M (2007) CEBPβ, JunD and c-Jun contribute to the transcriptional activation of the metastasis-associated C4.4A gene. Int J Cancer 120: 2135-2147
18. Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, Schmitz-Winnenthal FH, Horejsi V, Yoshie O, Herlyn D, Ashman LK, Zöller M (2005) Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 11: 2840-2852
19. Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP (2000) Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on {beta}-galactoside- mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 60: 2584-2588
20. Hansen LV, Gardsvoll H, Nielsen BS, Lund LR, Dano K, Jensen ON, Ploug M (2004) Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem J 380: 845-857
21. Izumi K, Hirao Y, Hopp L, Oyasu R (1981) In vitro induction of ornithine decarboxylase in urinary bladder carcinoma cells. Cancer Res 41: 405-409
22. Krishnan V, Bane SM, Kawle PD, Naresh KN, Kalraiya RD (2005) Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis 22: 11-24
23. Kuhn S, Koch M, Nübel T, Ladwein M, Antolovic D, Klingbeil P, Hildebrand D, Moldenhauer G, Langbein L, Franke WW, Weitz J, Zöller M (2007) Complex formation between CD44 variant isoforms with EpCAM and Claudin-7 in tetraspanin-enriched membrane microdomains promotes colorectal cancer progression. Mol Cancer Res 5: 553-567
24. Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schuring MP, Salmon I, Gabius HJ, Pector JC, Kiss R (2003) Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol 16: 491-504
25. Lehr J, Pienta K (1998) Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 90: 118-123
26. Matzku S, Wenzel A, Liu S, Zöller M (1989) Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 49: 1294-1299
27. Mazumdar A, Adam L, Boyd D, Kumar R (2001) Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res 61: 400-405
28. Mehul B, Corre C, Capon C, Bernard D, Schmidt R (2003) Carbohydrate expression and modification during keratinocyte differentiation in normal human and reconstructed epidermis. Exp Dermatol 12: 537-545
29. Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S (1999) Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer. Prostate 39: 123-129
30. Momburg F, Moldenhauer G, Hämmerling GJ, Möller P (1987) Immunohistochemical study of the expression of a Mr 34 000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47: 2883-2891
31. Montuori N, Visconte V, Rossi G, Ragno P (2005) Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? Thromb Haemost 93: 192-198
32. Nagy N, Legendre H, Engels O, Andre S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I, Kiss R (2003) Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 97: 1849-1858
33. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M (1999) Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15: 143-148
34. Orntoft TF, Vestergaard EM (1999) Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 20: 362-371
35. Pappot H, Hoyer-Hansen G, Ronne E, Hansen HH, Brunner N, Dano K, Grondahl-Hansen J (1997) Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients. Eur J Cancer 33: 867-872
36. Paret C, Bourouba M, Beer A, Miyazaki K, Schnölzer M, Fiedler S, Zöller M (2005) Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. Int J Cancer 115: 724-733
37. Ploug M, Ellis V (1994) Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett 349: 163-168
38. Ploug M, Eriksen J, Plesner T, Hansen NE, Dano K (1992) A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. Eur J Biochem 208: 397-404
39. Reisser D, Olsson NO, Martin F (1993) In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon-cancer cell variants. Int J Cancer 53: 651-656
40. Rösel M, Claas C, Seiter S, Herlevsen M, Zöller M (1998) Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene 17: 1989-2002
41. Schoeppner HL, Raz A, Ho SB, Bresalier RS (1995) Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75: 2818-2826
42. Seiter S, Stassar M, Rappl G, Reinhold U, Tilgen W, Zoller M (2001) Upregulation of C4.4A expression during progression of melanoma. J Invest Dermatol 116: 344-347
43. Sela BA, Steplewski Z, Koprowski H (1989) Colon carcinoma-associated glycoproteins recognized by monoclonal antibodies CO-029 and GA22-2. Hybridoma 8: 481-491
44. Sidenius N, Andolfo A, Fesce R, Blasi F (2002) Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J Biol Chem 277: 27982-27990
45. Sidenius N, Sier CF, Blasi F (2000) Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Lett 475: 52-56
46. Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Dano K, Brunner N, Blasi F (1998) The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 58: 1843-1849
47. Smith BA, Kennedy WJ, Harnden P, Selby PJ, Trejdosiewicz LK, Southgate J (2001) Identification of genes involved in human urothelial cell - matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res 61: 1678-1685
48. Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sorensen S, Dano K, Brunner N (1999) Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 91: 869-874
49. Stephens RW, Pedersen AN, Nielsen HJ, Hamers MJ, Hoyer-Hansen G, Ronne E, Dybkjaer E, Dano K, Brunner N (1997) ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem 43: 1868-1876
50. Taylor DD, Black PH (1986) Shedding of plasma membrane fragments. Neoplastic and developmental importance. Dev Biol 3: 33-57
51. Tsetlin V (1999) Snake venom alpha-neurotoxins and other 'three-finger' proteins. Eur J Biochem 264: 281-286
52. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269: 32380-32388
53. Wilhelm OG, Wilhelm S, Escott GM, Lutz V, Magdolen V, Schmitt M, Rifkin DB, Wilson EL, Graeff H, Brunner G (1999) Cellular glycosylphosphatidylinositol- specific phospholipase D regulates urokinase receptor shedding and cell surface expression. J Cell Physiol 180: 225-235
54. Würfel J, Seiter S, Stassar M, Claas A, Klas R, Rösel M, Marhaba R, Savelyeva L, Schwab M, Matzku S, Zöller M (2001) Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene 262: 35-41
55. Zöller M, Matzku S, Goerttler K (1978) High incidence of spontaneous transplantable tumours in BDX rats. Br J Cancer 37: 61-66